Skip to main content

PACIFIC BIOSCIENCES OF CALIFORNIA INC

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

PACB$2.36+4.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

Pacific Biosciences of California, Inc.
Date: February 28, 2024By:/s/ Christian O. Henry
Christian O. Henry
President and Chief Executive Officer
Date: February 28, 2024By:/s/ Susan G. Kim
Susan G. Kim
Chief Financial Officer
Date: February 28, 2024By:/s/ Michele Farmer
Michele Farmer
Vice President and Chief Accounting Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Christian O. Henry, Susan G. Kim, Brett Atkins, and Michele Farmer, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for each individual in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or the individual’s substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Christian O. HenryDirector, President and Chief Executive Officer(Principal Executive Officer)February 28, 2024
Christian O. Henry
/s/ Susan G. KimChief Financial Officer (Principal Financial Officer)February 28, 2024
Susan G. Kim
/s/ Michele FarmerVice President and Chief Accounting Officer (Principal Accounting Officer)February 28, 2024
Michele Farmer
/s/ John F. MilliganChairman of the Board of DirectorsFebruary 28, 2024
John F. Milligan
/s/ William W. EricsonDirectorFebruary 28, 2024
William W. Ericson
/s/ Hannah A. ValantineDirectorFebruary 28, 2024
Hannah A. Valantine
/s/ Randall S. LivingstonDirectorFebruary 28, 2024
Randall S. Livingston
/s/ Marshall L. MohrDirectorFebruary 28, 2024
Marshall L. Mohr
/s/ Kathy OrdoñezDirectorFebruary 28, 2024
Kathy Ordoñez
/s/ Lucy ShapiroDirectorFebruary 28, 2024
Lucy Shapiro
/s/ David MelineDirectorFebruary 28, 2024
David Meline
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.